Company
Adagene
Redefining the design and discovery of therapeutic antibodies
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
Record updated 28 September 2026
About
Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.